Last update 08 May 2025
MedVax Technologies

MedVax Technologies

Dissolved
| Private Company|2012|
< 10
|
www.medvax.net

Overview

Tags

Digestive System Disorders
Neoplasms
Therapeutic vaccine
Shared antigen vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Therapeutic vaccine1
Shared antigen vaccine1
Top 5 TargetCount
HER2(Receptor tyrosine-protein kinase erbB-2)1

Related

2
Drugs associated with MedVax Technologies
MX-402
Target
HER2
Mechanism
HER2 antagonists
Active Org.
MedVax TechnologiesMedVax Technologies
Originator Org.
MedVax TechnologiesMedVax Technologies
Active Indication
Stomach Cancer
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
INGN-225
Target
p53
Mechanism
P53 gene stimulants [+1]
Active Org.-
Originator Org.
MedVax TechnologiesMedVax Technologies
 [+2]
Active Indication-
Inactive Indication
Breast Cancer [+7]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with MedVax Technologies
Login to view more data
0 Patents (Medical) associated with MedVax Technologies
Login to view more data
100 Deals associated with MedVax Technologies
Login to view more data
100 Translational Medicine associated with MedVax Technologies
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MX-402
 ( HER2 )		Stomach Cancer
More
Phase 1
INGN-225
 ( p53 )		Small Cell Lung Cancer
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free